All lobbying filings
LMH Strategic Solutions
LMH Strategic Solutions filed a Q3 report for Mirum Pharmaceuticals, Inc. on October 19, 2026, reporting $20,000 in lobbying income.
Lobbying for Mirum Pharmaceuticals, Inc. · Biopharmaceutical company.
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$20,000
What the client paid this registrant for the period.
Client based in
California
Lobbyists on this filing
1
-
ALANNA TEMMEPreviously held: Legislative Director, U.S. Representative Jon Porter
Government bodies contacted
3
Lobbying activity
1
FDA issues.